| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/02/2002 | US20020052594 Method and kit for imaging and treating organs and tissues |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
| 05/02/2002 | US20020052469 Amino acid sequences for use in detection and treatment of viral infection |
| 05/02/2002 | US20020052412 Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
| 05/02/2002 | US20020052387 5-Substituted 2-aryl-4-pyrimidinones |
| 05/02/2002 | US20020052383 Phenylcycloalkylmethylamino and phenylalkenylamino derivatives, including 1-phenyl-2-aminomethylcyclopropanes; treatment of a variety of metabolic, feeding, and sexual disorders including obesity. |
| 05/02/2002 | US20020052365 Selective anxiolytic therapeutic agents |
| 05/02/2002 | US20020052358 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 05/02/2002 | US20020052317 Anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 05/02/2002 | US20020052316 Bax-mediated apoptosis modulating reagents and methods |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052051 Method and device for determining concentration of dioxins |
| 05/02/2002 | US20020052050 Device for determination of an analyte a in body fluid |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052018 Inward rectifier, g-protein activated, mammalian, potassium channels and uses thereof |
| 05/02/2002 | US20020052017 Diagnostic marker for vascular endothelial injury |
| 05/02/2002 | US20020052016 Monitoring and controlling biocatalytic efficiency of wastewater treatment; obtain activated sludge, sample wastewater, measure concentration of interior storage particles, adjust feed nutrients |
| 05/02/2002 | US20020052014 Peptide for use in detection of methylated proteins |
| 05/02/2002 | US20020052013 Tumour-specific P450 protein |
| 05/02/2002 | US20020052010 Method of evaluation and selection of absorbent article |
| 05/02/2002 | US20020052009 Detecting particles in sample; generate solid phase conjugated with biopolymer, incubate sample, detect presence and amount of preferential particles |
| 05/02/2002 | US20020052008 Isolating progentior cells, leukocytes and lymphocytes from sample, obtain sample, incubate with magnetic particles which bind preferential cells, apply magnetic and mechanical force, recover preferential cell |
| 05/02/2002 | US20020052006 Screening sample for an affinity modulator that binds protein target; obtain sample mix with modulator, incubate and allow complex formation, size-excluded mixture, dissociate particles, recover particles |
| 05/02/2002 | US20020052005 Construction and screening of lantibody display libraries |
| 05/02/2002 | US20020052002 Detection and amplification of ligands |
| 05/02/2002 | US20020052001 Assay |
| 05/02/2002 | US20020052000 Diagnostics for and mediators of inflammatory disorders |
| 05/02/2002 | US20020051999 Classifiying structures in a library; obtain matrix, calibrate mass measurements, monitor physical properties of particle in library |
| 05/02/2002 | US20020051992 Device for the analysis and monitoring of multiple samples on a solid support |
| 05/02/2002 | US20020051991 Rapid generation of diverse nucleoside and nucleotide libraries |
| 05/02/2002 | US20020051990 Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 05/02/2002 | US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 05/02/2002 | US20020051985 Signaling composition for use in detection of preferential particles in solution |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051980 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 05/02/2002 | US20020051979 Capillary bundles for use in the detection of preferential particle in sample |
| 05/02/2002 | US20020051978 Methods and compositions for the identification, assessment, prevention and therapy of human cancers |
| 05/02/2002 | US20020051976 Methods and compositions for polypeptide engineering |
| 05/02/2002 | US20020051975 Reporterless genosensors using electrical detection methods |
| 05/02/2002 | US20020051972 Polypeptide; for use in diagnosis and treatment of nervous system disorders, leukemia and cancer; antitumor agents |
| 05/02/2002 | US20020051970 Microarray-based subtractive hybridization |
| 05/02/2002 | US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases |
| 05/02/2002 | US20020051965 Modifications of the VEGF receptor-2 protein and methods of use |
| 05/02/2002 | US20020051883 Processing and manufacturing methods enabled using non-stoichiometric nanomaterials |
| 05/02/2002 | US20020051790 Helicobacter pylori; antigen of given amino acid sequences; superoxide dismutase in the form of a vaccine |
| 05/02/2002 | US20020051789 Method of identifying high immune response animals |
| 05/02/2002 | US20020051782 Anti-CCR2 antibodies and methods of use therefor |
| 05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
| 05/02/2002 | US20020051777 Method of modulating cellular activity |
| 05/02/2002 | US20020051760 Method for screening a substance having promoting activity on hair growth |
| 05/02/2002 | US20020051734 Vessel centering system and method |
| 05/02/2002 | US20020051132 Measuring method for concentration of halogen and fluorine compound, measuring equipment thereof and manufacturing method of halogen compound |
| 05/02/2002 | US20020050611 Hybrid electrical device with biological components |
| 05/02/2002 | US20020050355 Method of early predicting paraffin deposition risks during production and transport |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1202064A2 Method for detecting antibodies to and antigens of fungal and yeast exposures |
| 05/02/2002 | EP1202063A1 Immunoassay supports and immunoasssay solid phases with the use thereof |
| 05/02/2002 | EP1202062A1 Patterned surfaces for bioconjugation and their preparation |
| 05/02/2002 | EP1202061A1 Biosensor and blood component analyzing method |
| 05/02/2002 | EP1202060A1 Biosensor and method for its preparation |
| 05/02/2002 | EP1202059A1 Biosensor |
| 05/02/2002 | EP1202058A1 Chromatography measuring instrument |
| 05/02/2002 | EP1202057A2 Solid state microcuvette using dry films |
| 05/02/2002 | EP1202056A1 Continuous-flow homogeneous bio-chemical assays based on mass spectrometric detection of known ligands |
| 05/02/2002 | EP1202055A2 Magnetic resonance imaging device having magnetic field disturbance compensation |
| 05/02/2002 | EP1202046A1 Method and apparatus for determining biological species |
| 05/02/2002 | EP1202044A2 Method of polarimetry |
| 05/02/2002 | EP1201770A2 Oligonucleotide for highly sensitive detection of hepatitis c virus and method for detection thereof |
| 05/02/2002 | EP1201769A2 Gene expression monitoring using universal arrays |
| 05/02/2002 | EP1201767A2 Method of analyzing double stranded DNA |
| 05/02/2002 | EP1201766A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
| 05/02/2002 | EP1201765A2 Cellular kinases involved in cytomegalovirus infection and their inhibition |
| 05/02/2002 | EP1201764A2 Assays for identifying phosphatase inhibitors |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1200928A1 Transformation of digital images |
| 05/02/2002 | EP1200848A1 Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements |
| 05/02/2002 | EP1200838A1 Clinical control materials for bone resorptive markers |
| 05/02/2002 | EP1200837A1 A method for predicting the presence of haemostatic dysfunction in a patient sample |
| 05/02/2002 | EP1200836A1 Method for controlling the quality of the endothelium lining of natural blood vessels prostheses |
| 05/02/2002 | EP1200835A1 Methods for identification of compounds stimulating insulin secretion |
| 05/02/2002 | EP1200834A1 Method for screening molecules for the treatment of huntington disease |
| 05/02/2002 | EP1200833A1 Difference detection methods using matched multiple dyes |
| 05/02/2002 | EP1200832A1 Annexins and autoantibodies used as markers for cancer |
| 05/02/2002 | EP1200831A1 Modulating binding site on potassium channels used for screening |
| 05/02/2002 | EP1200830A1 Rodent detection |
| 05/02/2002 | EP1200829A2 Nmr rapid identification of bi-ligand drug candidates |
| 05/02/2002 | EP1200828A2 Methods of diagnosing and treating irritable bowel syndrome and other disorders |
| 05/02/2002 | EP1200827A2 Diagnosis of gluten sensitive enteropathy and other autoimmunopathies |
| 05/02/2002 | EP1200826A1 Internally referenced immunoassay and test device |
| 05/02/2002 | EP1200825A2 Method for detecting binding reactions through measurement of the relaxation of birefringence of magnetic nanoparticles |
| 05/02/2002 | EP1200823A1 A sensor comprising a hydrophilic matrix material |
| 05/02/2002 | EP1200822A1 Method for studying insulin action |
| 05/02/2002 | EP1200821A1 Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility |
| 05/02/2002 | EP1200820A2 Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
| 05/02/2002 | EP1200815A1 METHODS AND COMPOSITIONS FOR ASSURING REDUCTION OF NOx EMISSIONS FROM AN ENGINE BY SELECTIVE CATALYTIC REDUCTION |
| 05/02/2002 | EP1200814A1 Method and apparatus for determining quality properties of fish |
| 05/02/2002 | EP1200813A1 Method and apparatus for determining diffusible hydrogen concentrations |
| 05/02/2002 | EP1200805A1 Microsensor housing |